News

It pains me to think I won’t be able to fully see my grandchildren’s faces and fully experience the biggest moments of my ...
Deals with Hims & Hers, LifeMD and Ro following a court's dismissal of a lawsuit challenging the FDA's determination Wegovy ...
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...
Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.
A federal court in Texas has bolstered Novo Nordisk’s efforts to limit the production and sale of compounded versions of its GLP-1 drugs, Wegovy and Ozempic. Here are five notes: ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a ...
Novo Nordisk, the maker of Wegovy, announced exclusively on " Good Morning America " Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...
NVO's first-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...
Ozempic and similar weight loss drugs offer significant health benefits, including reduced heart disease risk and improved ...
Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...
Shares in Hims Hers Health Inc (NYSE:HIMS) soared over 40% on Tuesday after the telehealth group announced a "long-term collaboration" with Novo Nordisk A/S (NYSE:NVO) to offer the Danish firm’s ...